Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118020872 | 11802087 | 2 | F | 20130213 | 20160628 | 20151204 | 20160701 | EXP | JP-SA-2015SA199672 | AVENTIS | 71.00 | YR | E | M | Y | 70.30000 | KG | 20160701 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118020872 | 11802087 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | UNK | 103869 | 225 | MG | INJECTION | QD | ||||||
| 118020872 | 11802087 | 2 | SS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | UNK | 103869 | 225 | MG | INJECTION | QD | ||||||
| 118020872 | 11802087 | 3 | SS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | UNK | 103869 | 2.5 | MG | INJECTION | 1X | ||||||
| 118020872 | 11802087 | 4 | C | CICLOSPORIN | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 118020872 | 11802087 | 5 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 0 | ||||||||||||
| 118020872 | 11802087 | 6 | C | HUMULIN R | INSULIN HUMAN | 1 | 0 | ||||||||||||
| 118020872 | 11802087 | 7 | C | NEORAL | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 118020872 | 11802087 | 8 | C | CRAVIT | LEVOFLOXACIN | 1 | 0 | ||||||||||||
| 118020872 | 11802087 | 9 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 0 | ||||||||||||
| 118020872 | 11802087 | 10 | C | ASTRIC | ACYCLOVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118020872 | 11802087 | 1 | Aplastic anaemia |
| 118020872 | 11802087 | 2 | Aplastic anaemia |
| 118020872 | 11802087 | 3 | Aplastic anaemia |
| 118020872 | 11802087 | 4 | Aplastic anaemia |
| 118020872 | 11802087 | 5 | Prophylaxis |
| 118020872 | 11802087 | 6 | Diabetes mellitus |
| 118020872 | 11802087 | 7 | Aplastic anaemia |
| 118020872 | 11802087 | 8 | Prophylaxis |
| 118020872 | 11802087 | 9 | Prophylaxis |
| 118020872 | 11802087 | 10 | Antiviral prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118020872 | 11802087 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118020872 | 11802087 | Anaemia | |
| 118020872 | 11802087 | Lymphocyte count decreased | |
| 118020872 | 11802087 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118020872 | 11802087 | 1 | 20130212 | 20130214 | 0 | |
| 118020872 | 11802087 | 2 | 20130215 | 20130216 | 0 | |
| 118020872 | 11802087 | 3 | 20130212 | 20130212 | 0 | |
| 118020872 | 11802087 | 4 | 20130110 | 0 | ||
| 118020872 | 11802087 | 5 | 20130212 | 20130216 | 0 | |
| 118020872 | 11802087 | 6 | 20130212 | 20130217 | 0 | |
| 118020872 | 11802087 | 7 | 20130110 | 0 | ||
| 118020872 | 11802087 | 8 | 20121210 | 0 | ||
| 118020872 | 11802087 | 9 | 20121220 | 0 | ||
| 118020872 | 11802087 | 10 | 20120124 | 0 |